Cite
HARVARD Citation
Healey, G. et al. (2019). Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer. Journal for immunotherapy of cancer. 7 (1), p. . [Online].